These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2574719)

  • 1. A comparison of two adjunctive treatment strategies in acute mania.
    Busch FN; Miller FT; Weiden PJ
    J Clin Psychiatry; 1989 Dec; 50(12):453-5. PubMed ID: 2574719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in treatment of acute mania.
    Chou JC
    J Clin Psychopharmacol; 1991 Feb; 11(1):3-21. PubMed ID: 1674948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [General practice of acute inpatient treatment of mania. Retrospective comparative study of 100 patients at each of 2 psychiatric centers].
    Adler L; Ulrich M; Lehmann K; Nordeck I; Langer C; Thomas RS; Hajak G; Koller M
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):479-88. PubMed ID: 7835819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
    Lenox RH; Newhouse PA; Creelman WL; Whitaker TM
    J Clin Psychiatry; 1992 Feb; 53(2):47-52. PubMed ID: 1541605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
    Reischies FM; Hartikainen J; Berghöfer AM
    Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic exposure in bipolar outpatients in a research setting.
    Denicoff KD; Sollinger AB; Frye MA; Ali SO; Smith-Jackson EE; Leverich GS; Post RM
    Compr Psychiatry; 2000; 41(4):248-52. PubMed ID: 10929791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy in bipolar disorder].
    Nolen WA
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1299-305. PubMed ID: 10416483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuroleptics in manic-depressive illness.
    Kane JM
    J Clin Psychiatry; 1988 Nov; 49 Suppl():12-4. PubMed ID: 2903142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic].
    Reetz-Kokott U; Müller-Oerlinghausen B
    Nervenarzt; 1996 Mar; 67(3):229-34. PubMed ID: 8901281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute inpatient treatment of manias. Effects of independent variables on neuroleptic dosage and length of stay].
    Adler L; Ulrich M; Lehmann K; Nordeck I; Langer C; Thomas RS; Hajak G; Koller M
    Nervenarzt; 1996 Mar; 67(3):235-43. PubMed ID: 8901282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine: new indication. New indication in acute mania: just another neuroleptic.
    Prescrire Int; 2004 Apr; 13(70):45-7. PubMed ID: 15148954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic.
    Sernyak MJ; Griffin RA; Johnson RM; Pearsall HR; Wexler BE; Woods SW
    Am J Psychiatry; 1994 Jan; 151(1):133-5. PubMed ID: 7903511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.
    DeCarolis DD; Rice KL; Ho L; Willenbring ML; Cassaro S
    Pharmacotherapy; 2007 Apr; 27(4):510-8. PubMed ID: 17381377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to lithium carbonate.
    Krishna NR; Taylor MA; Abrams R
    Biol Psychiatry; 1978 Oct; 13(5):601-6. PubMed ID: 31948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.